Back to Crohns Disease And Colitis

NCT00562887

NCT00562887
Terminated Phase 2 🇦🇺 Australian site

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with Crohn's disease for more than 4 months, confirmed by a camera examination of the gut or an imaging scan.
  • Your Crohn's disease activity falls within a specific range on a scoring system (called the CDAI) at the start of the trial, meaning your disease is moderately to severely active (confirm with trial site).
  • You are aged 18 or older but under 75 years old at the time of your screening visit.
  • The trial doctor considers you to be in generally good health overall.

Who may not be able to join:

  • You have been diagnosed with a type of bowel inflammation other than Crohn's disease.
  • You have a known narrowing in your bowel (called a stricture) that is causing symptoms.
  • You have had bowel surgery in the past 6 months, or you are planning to have bowel surgery at any point during the study.
  • You have a stoma bag or a specific type of surgically created internal pouch (people who have had a certain type of bowel reconnection surgery may still be eligible — confirm with trial site).
  • The trial doctor has determined that you have short bowel syndrome (a condition where your body cannot absorb enough nutrients).
  • You currently have an infection or have factors that put you at high risk of serious infections.
  • You are pregnant, planning to become pregnant during the study, or are currently breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Terminated
Phase
Phase 2
Sponsor
Abbott
Registry
clinicaltrials_gov
Start date
1 November 2007
Est. completion
1 April 2010

Where this trial is recruiting

🇦🇺 Australia 🇦🇹 Austria 🇧🇪 Belgium 🇨🇦 Canada 🇩🇰 Denmark Puerto Rico 🇺🇸 United States

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Proportion of subjects achieving clinical remission, defined as CDAI score of <150 points

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov